<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805531/bin/13000_2019_900_Fig1_HTML.jpg"/> </div> <div class="text-side"> <h1>Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.</h1> <p>FOXP3 density in lymphomatoid papulomatosis (LyP) and primary cutaneous anaplastic large cell lymphoma (pcALCL): a- LyP showing few CD30 positive neoplastic cells (100X). b- FOXP3 positive cells distribution throughout LyP lesion (100X). c- The distribution of FOXP3 positive cells was enriched in the center of LyP (400X). d- pcALCL showing diffuse positivity for CD30 (100X). e- Presence of scattered FOXP3 positive cells in the center of pcALCL (400X). f- The distribution of FOXP3 positive cells was enriched in the edge of pcALCL (400X)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31640798/" target="_blank">31640798</a></p><p>Type: Premalignant/Malignant, Category: Hematolymphoid</p>
</div> </div></div></body></html>